Globe Life Inc. (NYSE:GL – Get Free Report) CFO Thomas Peter Kalmbach sold 25,650 shares of the firm’s stock in a transaction that occurred on Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total value of $4,580,577.00. Following the completion of the sale, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,030,433.44. This represents a 33.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Thursday, July 30th, Thomas Peter Kalmbach sold 21,000 shares of Globe Life stock. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00.
- On Friday, May 22nd, Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock. The stock was sold at an average price of $156.59, for a total value of $1,242,698.24.
- On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The stock was sold at an average price of $156.61, for a total value of $1,864,128.83.
- On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The shares were sold at an average price of $152.02, for a total value of $1,792,315.80.
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The shares were sold at an average price of $153.65, for a total transaction of $2,402,625.05.
Globe Life Stock Performance
GL stock opened at $182.65 on Friday. The company has a 50-day simple moving average of $171.01 and a 200 day simple moving average of $154.07. The company has a market capitalization of $14.18 billion, a P/E ratio of 12.13 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life Inc. has a fifty-two week low of $127.85 and a fifty-two week high of $191.55.
Analyst Ratings Changes
Several equities research analysts recently commented on the company. Keefe, Bruyette & Woods dropped their target price on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. Weiss Ratings lowered Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. Wells Fargo & Company lifted their price target on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Piper Sandler boosted their price objective on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 15th. Finally, Truist Financial upped their price objective on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $191.67.
Check Out Our Latest Stock Analysis on GL
Institutional Trading of Globe Life
Hedge funds and other institutional investors have recently made changes to their positions in the business. Hilton Head Capital Partners LLC acquired a new position in Globe Life in the fourth quarter worth approximately $30,000. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life in the second quarter valued at $28,000. MUFG Securities EMEA plc bought a new position in shares of Globe Life in the second quarter valued at $31,000. Torren Management LLC acquired a new stake in shares of Globe Life during the 4th quarter valued at $37,000. Finally, AdvisorNet Financial Inc lifted its position in shares of Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Further Reading
- Five stocks we like better than Globe Life
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
